{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:15:03Z","timestamp":1793952903474,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Santen Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although traditional surgical procedures for glaucoma (such as trabeculectomy and tube-shunt implantation) can significantly reduce intraocular pressure (IOP), they are associated with numerous complications, some of which are vision-threatening, or involve prolonged recovery or a highly intensive postoperative course. Micro-invasive glaucoma surgery (MIGS) procedures have shown better safety but reduced efficacy in achieving target IOP. Combinations of these methods have led to the development of subconjunctival micro-invasive procedures with safety comparable to traditional surgery and greater efficacy than minimally invasive methods. This review describes the use of one of these devices, the poly(styrene-<jats:italic>block<\/jats:italic>-isobutylene-<jats:italic>block<\/jats:italic>-styrene) (SIBS)-based PreserFlo MicroShunt (Santen, Emeryville, CA), in the surgical treatment of patients with glaucoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main text<\/jats:title>\n                <jats:p>The MicroShunt is an 8.5-mm tube made of an inert polymer with no endplate, an internal diameter of 70\u00a0\u03bcm, and fins intended to prevent peritubular flow and anchor the device within the sclera to prevent proximal migration into the eye. Following ab externo implantation, the tube provides a conduit for flow of aqueous humor from the anterior chamber into the subconjunctival\/sub-Tenon space. Clinical trials to date have shown that, when paired with mitomycin C (MMC) treatment, MicroShunt implantation significantly reduced both IOP and the number of glaucoma medications. These IOP-lowering results were found both when surgery was performed alone and with phacoemulsification. The MicroShunt also showed a safety profile comparable to that of traditional filtering surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The MicroShunt and other novel subconjunctival procedures have shown substantial IOP reductions while mitigating hypotony-related complications. MMC, which modulates fibrosis and scarring postoperatively, is essential to surgical success. Randomized, long-term clinical trials will further clarify the role of controlled micro-incisional device-assisted ab externo glaucoma filtering surgery in long-term glaucoma management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40662-022-00322-1","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T01:02:51Z","timestamp":1677718971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma"],"prefix":"10.1186","volume":"10","author":[{"given":"Iqbal Ike K.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Sadruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Panarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"issue":"4","key":"322_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312\u201334.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"322_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL, et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789\u2013803.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"322_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ajo.2011.10.024","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804\u201314.","journal-title":"Am J Ophthalmol"},{"key":"322_CR4","first-page":"189","volume":"10","author":"GM Richter","year":"2016","unstructured":"Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016;10:189\u2013206.","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"322_CR5","doi-asserted-by":"publisher","first-page":"e0183142","DOI":"10.1371\/journal.pone.0183142","volume":"12","author":"C Lavia","year":"2017","unstructured":"Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS One. 2017;12(8):e0183142.","journal-title":"PLoS ONE"},{"key":"322_CR6","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/OPTH.S135316","volume":"11","author":"LE Pillunat","year":"2017","unstructured":"Pillunat LE, Erb C, J\u00fcnemann AG, Kimmich F. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin Ophthalmol. 2017;11:1583\u2013600.","journal-title":"Clin Ophthalmol"},{"key":"322_CR7","doi-asserted-by":"publisher","first-page":"3182935","DOI":"10.1155\/2017\/3182935","volume":"2017","author":"DZ Chen","year":"2017","unstructured":"Chen DZ, Sng CCA. Safety and efficacy of microinvasive glaucoma surgery. J Ophthalmol. 2017;2017:3182935.","journal-title":"J Ophthalmol"},{"issue":"2","key":"322_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","volume":"23","author":"H Saheb","year":"2012","unstructured":"Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96\u2013104.","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"322_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/rb\/rbw005","volume":"3","author":"L Pinchuk","year":"2016","unstructured":"Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E, et al. The use of poly(styrene-block-isobutylene-block-styrene) as a microshunt to treat glaucoma. Regen Biomater. 2016;3(2):137\u201342.","journal-title":"Regen Biomater"},{"issue":"1","key":"322_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jbm.b.33525","volume":"105","author":"L Pinchuk","year":"2017","unstructured":"Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E, et al. The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 2017;105(1):211\u201321.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"12","key":"322_CR11","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1001\/archopht.124.12.1742","volume":"124","author":"AC Acosta","year":"2006","unstructured":"Acosta AC, Espana EM, Yamamoto H, Davis S, Pinchuk L, Weber BA, et al. A newly designed glaucoma drainage implant made of poly(styrene-b-isobutylene-b-styrene): biocompatibility and function in normal rabbit eyes. Arch Ophthalmol. 2006;124(12):1742\u20139.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"322_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jfo.2015.05.005","volume":"38","author":"I Riss","year":"2015","unstructured":"Riss I, Batlle J, Pinchuk L, Kato YP, Weber BA, Parel JM. One-year results on the safety and efficacy of the InnFocus MicroShunt\u2122 depending on placement and concentration of mitomycin C. J Fr Ophtalmol. 2015;38(9):855\u201360.","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"322_CR13","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1097\/IJG.0000000000000368","volume":"25","author":"JF Batlle","year":"2016","unstructured":"Batlle JF, Fantes F, Riss I, Pinchuk L, Alburquerque R, Kato YP, et al. Three-year follow-up of a novel aqueous humor MicroShunt. J Glaucoma. 2016;25(2):e58\u201365.","journal-title":"J Glaucoma"},{"issue":"3","key":"322_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/IJG.0000000000001734","volume":"30","author":"JF Batlle","year":"2021","unstructured":"Batlle JF, Corona A, Albuquerque R. Long-term results of the PRESERFLO MicroShunt in patients with primary open-angle glaucoma from a single-center nonrandomized study. J Glaucoma. 2021;30(3):281\u20136.","journal-title":"J Glaucoma"},{"issue":"1","key":"322_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10384-021-00893-x","volume":"66","author":"T Ahmed","year":"2022","unstructured":"Ahmed T, Honjo M, Sakata R, Fujishiro T, Shirato S, Aihara M. Long-term results of the safety and effectiveness of a novel microshunt in Japanese patients with primary open angle glaucoma. Jpn J Opthalmol. 2022;66(1):33\u201340.","journal-title":"Jpn J Opthalmol"},{"key":"322_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2020.02.020","volume":"215","author":"MB Schlenker","year":"2020","unstructured":"Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS Microshunt with mitomycin C. Am J Ophthalmol. 2020;215:141\u201353.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"322_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bjophthalmol-2020-317299","volume":"106","author":"GM Durr","year":"2022","unstructured":"Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma. Br J Ophthalmol. 2022;106(1):71\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"322_CR18","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.ophtha.2021.05.023","volume":"128","author":"ND Baker","year":"2021","unstructured":"Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK, et al. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021;128(12):1710\u201321.","journal-title":"Ophthalmology"},{"key":"322_CR19","unstructured":"Panarelli JF, Baker ND, Stiles MC, Moster MR, Beckers HJM. Safety and effectivess of microshunt versus trabeculectomy: results from a 2-year randomized, multicenter study. In: American Academy of Ophthalmology Annual Meeting. USA: New Orleans, LA; 2021."},{"issue":"2","key":"322_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers HJM, Aptel F, Webers CAB, Bluwol E, Mart\u00ednez-de-la-Casa JM, Garc\u00eda-Feijo\u00f3 J, et al. Safety and effectiveness of the PRESERFLO\u00ae MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Opthalmol Glaucoma. 2022;5(2):195\u2013209.","journal-title":"Opthalmol Glaucoma"},{"issue":"3","key":"322_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/0974-9233.56220","volume":"16","author":"S Dhingra","year":"2009","unstructured":"Dhingra S, Khaw PT. The Moorfields safer surgery system. Middle East Afr J Ophthalmol. 2009;16(3):112\u20135.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"4","key":"322_CR22","first-page":"CD002897","volume":"2005","author":"M Wilkins","year":"2005","unstructured":"Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005;2005(4):CD002897.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"322_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.survophthal.2020.05.005","volume":"66","author":"K Bell","year":"2021","unstructured":"Bell K, de Padua Soares Bezerra B, Mofokeng M, Montesano G, Nongpiur ME, Marti MV, et al. Learning from the past: mitomycin C use in trabeculectomy and its application in bleb-forming minimally invasive glaucoma surgery. Surv Ophthalmol. 2021;66(1):109\u201323.","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"322_CR24","first-page":"612","volume":"25","author":"A Neelakantan","year":"1994","unstructured":"Neelakantan A, Rao BS, Vijaya L, Grandham SB, Krishnan N, Priya VS, et al. Effect of the concentration and duration of application of mitomycin C in trabeculectomy. Ophthalmic Surg. 1994;25(9):612\u20135.","journal-title":"Ophthalmic Surg"},{"issue":"1","key":"322_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF00156420","volume":"19","author":"H Mietz","year":"1995","unstructured":"Mietz H, Krieglstein GK. Short-term clinical results and complications of trabeculectomies performed with mitomycin C using different concentrations. Int Ophthalmol. 1995;19(1):51\u20136.","journal-title":"Int Ophthalmol"},{"issue":"1","key":"322_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0161-6420(97)30347-9","volume":"104","author":"JC Cheung","year":"1997","unstructured":"Cheung JC, Wright MM, Murali S, Pederson JE. Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology. 1997;104(1):143\u20139.","journal-title":"Ophthalmology"},{"issue":"1","key":"322_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3341\/kjo.1996.10.1.42","volume":"10","author":"JJ Lee","year":"1996","unstructured":"Lee JJ, Park KH, Youn DH. The effect of low- and high-dose adjunctive mitomycin C in trabeculectomy. Korean J Ophthalmol. 1996;10(1):42\u20137.","journal-title":"Korean J Ophthalmol"},{"issue":"8","key":"322_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archopht.1997.01100160139001","volume":"115","author":"AL Robin","year":"1997","unstructured":"Robin AL, Ramakrishnan R, Krishnadas R, Smith SD, Katz JD, Selvaraj S, et al. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol. 1997;115(8):969\u201374.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"322_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3928\/1542-8877-19980801-04","volume":"29","author":"H Mietz","year":"1998","unstructured":"Mietz H, Krieglstein GK. Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. Ophthalmic Surg Lasers. 1998;29(8):628\u201334.","journal-title":"Ophthalmic Surg Lasers"},{"key":"322_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ajo.2020.07.002","volume":"220","author":"JL Do","year":"2020","unstructured":"Do JL, Xu BY, Wong B, Camp A, Ngai P, Long C, et al. A randomized controlled trial comparing subconjunctival injection to direct scleral application of mitomycin C in trabeculectomy. Am J Ophthalmol. 2020;220:45\u201352.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"322_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4103\/ijo.IJO_963_19","volume":"68","author":"D Maheshwari","year":"2020","unstructured":"Maheshwari D, Kanduri S, Rengappa R, Kadar MA. Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: one-year study. Indian J Ophthalmol. 2020;68(4):615\u20139.","journal-title":"Indian J Ophthalmol"},{"key":"322_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ajo.2020.03.002","volume":"216","author":"MC Lim","year":"2020","unstructured":"Lim MC, Hom B, Watnik MR, Brandt JD, Altman AR, Paul T, et al. A comparison of trabeculectomy surgery outcomes with mitomycin-C applied by intra-tenon injection versus sponge. Am J Ophthalmol. 2020;216:243\u201356.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"322_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5005\/jp-journals-10078-1254","volume":"13","author":"ME Guimar\u00e3es","year":"2019","unstructured":"Guimar\u00e3es ME, de P\u00e1dua Soares Bezerra B, de Miranda Cordeiro F, Carvalho CH, Danif DN, Prata TS, et al. Glaucoma surgery with soaked sponges with mitomycin C vs sub-tenon injection: short-term outcomes. J Curr Glaucoma Pract. 2019;13(2):50\u20134.","journal-title":"J Curr Glaucoma Pract"},{"issue":"1","key":"322_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ogla.2018.06.003","volume":"1","author":"H Esfandiari","year":"2018","unstructured":"Esfandiari H, Pakravan M, Yazdani S, Doozandeh A, Yaseri M, Conner IP. Treatment outcomes of mitomycin C-augmented trabeculectomy, sub-Tenon injection versus soaked sponges, after 3 years of follow-up: a randomized clinical trial. Ophthalmol Glaucoma. 2018;1(1):66\u201374.","journal-title":"Ophthalmol Glaucoma"},{"issue":"9","key":"322_CR35","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/bjophthalmol-2016-309671","volume":"101","author":"M Pakravan","year":"2017","unstructured":"Pakravan M, Esfandiari H, Yazdani S, Douzandeh A, Amouhashemi N, Yaseri M, et al. Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial. Br J Ophthalmol. 2017;101(9):1275\u201380.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-022-00322-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-022-00322-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-022-00322-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T01:04:25Z","timestamp":1677719065000},"score":1,"resource":{"primary":{"URL":"https:\/\/eandv.biomedcentral.com\/articles\/10.1186\/s40662-022-00322-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["322"],"URL":"https:\/\/doi.org\/10.1186\/s40662-022-00322-1","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ike Ahmed has the following disclosures: Aequus: C; Aerie Pharmaceuticals: C, R; Akorn: C; Alcon: C,\u00a0S,\u00a0R; Allergan: C,\u00a0S,\u00a0R; Aquea Health, Inc: C; ArcScan: C; Avisi: C; Bausch Health: C; Beaver Visitec: C; Beyeonics: C; Bionode: C, R; Carl Zeiss Meditec: C,\u00a0S; Centricity Vision, Inc: C; CorNeat Vision: C; Custom Surgical: C; Elios Vision: C; ElutiMed: C; Equinox: C; eyeFlow, Inc: C; Genentech: C; Glaukos: C, R; Gore: C; Heine: C, S; Heru: C; Iantrek: C; InjectSense: C; Iridex: C; iCare: R; iStar: C; Ivantis: C, R; Johnson & Johnson Vision: C, S, R; Labtician Thea: C; LayerBio: C; Leica Microsystems: C; Life Long Vision: C; Long Bridge Medical, Inc: C; MicroOptx: C; MST Surgical: C, S; Myra Vision: C; New World Medical: C, R; Ocular Instruments: C; Ocular Therapeutix: C; Oculo: C; Omega Ophthalmics: C; PolyActiva: C; PulseMedica: C; Radiance Therapeutics, Inc: C; Ripple Therapeutics: C; Sanoculis: C; Santen: C, R; Shifamed, LLC: C.\u00a0Sight Sciences: C; Smartlens, Inc: C; Stroma: C; Thea Pharma: C; ViaLase: C; Visus Therapeutics: C; Vizzario: C; VSY Biotechnology: C; Zilia, Inc: C.\u00a0Joseph F. Panarelli has the following disclosures: Aerie Pharmaceuticals: C; Allergan: C, R; CorneaGen: C; Glaukos: C; New World Medical: C; Santen: C.\u00a0Omar Sadruddin was an employee of Santen, Inc.\u00a0at the time of manuscript submission. Currently, he is employed at Glaukos Corporation.\u00a0C \u2013 consultant\/consulting fees; S \u2013 speakers honoraria; R \u2013 research grant\/support.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}